Search filters

List of works by Niamh E Buckley

A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer

scientific article published on 27 June 2019

Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer

scientific article published on 02 November 2021

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer

scientific article published on 17 December 2018

BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers

scientific article published on November 28, 2011

BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers

scientific article published on July 17, 2013

BRCA1 – Conductor of the Breast Stem Cell Orchestra: The Role of BRCA1 in Mammary Gland Development and Identification of Cell of Origin of BRCA1 Mutant Breast Cancer

scientific article published on September 1, 2012

Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

scientific article published on 20 May 2020

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention

scientific article published on 9 December 2015

NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

scientific article published on 02 April 2019

PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer

scientific article published on 18 March 2019

Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer

scientific article published on 09 March 2020

Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatment

scientific article published on 21 March 2016

TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells

scientific article published on 28 June 2019

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities

scientific article